Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 391 AL 405

ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy

Perales MA, Dietrich J, Gust J, Santomasso B, Rejeski K, Hansen D, Shah NN, Berdeja J, Bishop M, Bleickardt E, Brudno J, Dahiya S, Frey N, Frigault MJ, Gardner R, Ghobadi A, Grupp S, Hamadani M, Jacobson C, Jain MD, Jain T, Komanduri KV, Kumar A, Lim S, Lin Y, Miao H, Neelapu S, Otegbeye F, Park JH, Pasquini M, Patel N, Plautz G, Verdun N, Lee DW, Maus MV, Locke FL.

Transplant Cell Ther. 2026 Oct;32(10):1189-1211. doi: 10.1016/j.jtct.2026.05.020. Epub 2026 Sep 8.

Harmonized Acquisition of Connectome MRI and Clinical Data for Stroke, Parkinson's Disease and Glioma: Delphi-Derived Protocol Recommendations by the European Academy of Neurology

Berger T, Pini L, Salvalaggio A, Cauzzo S, Klein C, Lolich M, Picca A, Ramankulov D, Rocca MA, Rudà R, Sodero A, Tessitore A, Truelsen T, Wiest R, Fink GR, Moro E, Ryvlin P, Corbetta M.

Eur J Neurol. 2026 Sep;33(9):e70708. doi: 10.1111/ene.70708.

Multi-centre randomised controlled feasibility trial with embedded process evaluation of a samba percussion intervention for people living with Parkinson's disease: a protocol for the Sparky Samba trial

Hamilton R, Malin E, Kirby N, Williams-Thomas R, Pallmann P, Smallman K, Mclauchlan D, Jacob N, Baxter J, Jones C, Metzler-Baddeley C, Hamana K, Drew CJ.

BMJ Open. 2026 Sep 9;16(9):e114372. doi: 10.1136/bmjopen-2025-114372.

Update on Parkinson's Disease Psychosis: Epidemiology, Mechanisms and Management

Kruse C, Weintraub D, Duda J, Morley JF.

Neurol Ther. 2026 Sep 9. doi: 10.1007/s40120-026-01014-x. Online ahead of print.

Evaluating the Swallow-Tail Sign on susceptibility-weighted imaging (SWI) for Parkinson's disease diagnosis: A bivariate meta-analysis

Ohannesian VA, Ishizuka BM, Tudino CHS, Rajchenberg D, Falcão L, Alvarez MB, Alvarez GB, Rodrigues A, Menezes IR, Francisco Neto MJ, Taneja AK.

J Neuroradiol. 2026 Sep 10;53(6):101602. doi: 10.1016/j.neurad.2026.101602. Online ahead of print.

Nitric oxide signaling and mitophagy in Parkinson's disease: implications for aerobic exercise-related neuroprotection

Zhou Y, Wu Y.

Med Gas Res. 2027 Jan 1;17(1):129-138. doi: 10.4103/mgr.MEDGASRES-D-26-00008. Epub 2026 Sep 12.

Adaptive versus conventional deep brain stimulation for bradykinesia in Parkinson's disease: a comparative effectiveness analysis

Tchantchaleishvili N, Natsvaladze T, Netliukh A, Su Z, Ganau M.

Acta Neurol Belg. 2026 Sep 14. doi: 10.1007/s13760-026-03192-9. Online ahead of print.

The Impact of Anticholinergic Burden on Cognitive Function and Adverse Events Among Patients with Parkinson's Disease: A Meta-Analysis

Wang YF, Tseng IJ, Lin CF, Lin CH, Liao SF, Wang YH, Lee HH.

Curr Neuropharmacol. 2026 Sep 10. doi: 10.2174/011570159X464947260902052340. Online ahead of print.

LRRK2: Molecular Mechanisms in Parkinson's Disease

Arias-Carrión O, Guerra-Crespo M, Ortuño-Sahagún D, Ortega-Robles E.

Int J Mol Sci. 2026 Aug 25;27(17):7606. doi: 10.3390/ijms27177606.

Rethinking the concept of disease modification in an evolving Parkinson's disease treatment landscape

Antonini A, Gross RE, De Leon M, Kwok K, Foltynie T, Höglinger G, Gasser T, Corvol JC, Pedrosa DJ, Volkmann J, Henchcliffe C.

J Parkinsons Dis. 2026 Sep 15:1877718X261481704. doi: 10.1177/1877718X261481704. Online ahead of print.

Understanding Neuropsychiatric Fluctuations in Parkinson's Disease: From Mechanisms to Management

Sousa M, Amstutz D, Natera-Villalba E, Krack P, Martínez-Fernández R.

Mov Disord Clin Pract. 2026 Sep 15:10.1002/mdc3.70771. doi: 10.1002/mdc3.70771. Online ahead of print.

Repurposing Anticancer Drugs in Parkinson's Treatment: Molecular Pathways Driving Neuroprotection and Therapeutic Advancement

Bedage PL, Dhanush Y, Chettri P, Shivakumar, Ahmed SS, Raghunathanaidu BD.

Mol Neurobiol. 2026 Sep 16;63(1):899. doi: 10.1007/s12035-026-06207-x.

Pathogenesis of the Holmes tremor due to cerebellar lesions: A case series with a narrative review

Nakamura M, Isono O.

J Neurol Sci. 2026 Nov 15;490:126163. doi: 10.1016/j.jns.2026.126163. Epub 2026 Sep 6.

Data-driven subtyping of Parkinson's disease using MRI: current insights, challenges, and future directions

Vijayakumari AA, Sakaie KE, Fernandez HH, Walter BL.

Front Aging Neurosci. 2026 Sep 3;18:1819248. doi: 10.3389/fnagi.2026.1819248. eCollection 2026.

The effect of neurodegeneration on ultrasonic vocalisations (USV) and their neuronal substrates in mice and rats: A systematic review

Calemi C, Bruffaerts R, Ellender T.

Neurobiol Aging. 2026 Sep 17;169:69-87. doi: 10.1016/j.neurobiolaging.2026.09.006. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias